November 18, 2009
In the midst of the U.S. healthcare debate comes another reason why everyone of us should have basic health coverage. A new study by Harvard University researchers found that uninsured patients with traumatic injuries (such as car crashes, falls and gunshot wounds) were almost twice as likely to die in the hospital as similarly injured patients with health insurance. Taking into account injury severity, race, gender and age uninsured patients were still 80% more likely to die than those with insurance, including Medicaid. It’s shocking and unclear just why the uninsured fare worse in terms of ER care, since it’s largely assumed – and federally mandated – that all unstable patient receive equal care in ERs. One reason this might occur is that private hospitals can transfer uninsured patients to public hospitals once patients are stable. A transfer could then worsen a patient’s condition by delaying treatment. The findings are based on an analysis of data from the National Trauma Data Bank, which includes more than 900 U.S. hospitals. [via New York Times]
Share your comments here.
Posted by Steven / November 18, 2009 6:40 pm / Permalink / Comments (10) / Trackbacks (0)
November 16, 2009
Swedish researchers are reporting positive outcomes in a study examining the use of a device called RhinoChill, which cools the brains of heart attack patients by pumping coolant into the patient’s nose during CPR. In patients where resuscitation efforts began within 10 minutes of cardiac arrest researchers found that 59.1% of cooled patients and 29.4% of standard care patients survived to hospital discharge; 45.5% of cooled patients and 17.6% of standard care patients were neurologically intact at hospital discharge. The results also suggest that the earlier the cooling is started the better. When cooling efforts were delayed, there was no significant difference in survival when compared to those who did not receive nasal cooling. During a heart attack the heart is unable to properly pump blood to the brain (and other vital organs) which can lead to subsequent brain injury. [via Medline Plus]
Share your comments here.
Posted by Steven / November 16, 2009 9:32 pm / Permalink / Comments (1) / Trackbacks (0)
November 13, 2009
Telomeres have been a focus of anti-aging research for quite sometime. Unfortunately, no breakthroughs have yet revealed any glimmer of the fountain of youth. Telomeres are pieces of DNA that cap the ends of our chromosomes. Each time a cell divides (which is required for us to stay alive) telomeres get shorter and shorter until they reach a point where division is halted, thus putting bodily cells into a state where they can no longer renew themselves – thus is part of the aging process. However, new research focusing on Ashkenazi Jews has found that those who lived the longest had inherited a hyperactive version of an enzyme called telomerase that is able to rebuild telomeres. “In effect, centenarians tend to have a top-notch body mechanic at work 24/7 repairing the hardware that runs the body, versus a normal person whose body’s cellular control center is left to wear out with time.” Will this startling research lead to future advances in the pursuit of longevity? Only time will tell. [via Yahoo! News]
Share your comments here.
Posted by Steven / November 13, 2009 12:06 am / Permalink / Comments (6) / Trackbacks (0)
November 9, 2009
The journal Cancer reports on a new study which shows that women previously treated for breast cancer have a higher risk of cancer recurrence if they have highly dense breasts. Women who were classified as having highly dense breasts had a 21% chance of cancer recurrence, compared to 5% among women with low-density breasts. Because of this the study authors suggest that women with highly dense breasts may benefit from additional therapies, such as radiation, after breast and lymph node surgery. [via Medical News Today]
Share your comments here.
Posted by Steven / November 9, 2009 6:14 pm / Permalink / Comments (4) / Trackbacks (0)
November 8, 2009
The Sahlgrenska Academy at the University of Gothenburg, Sweden released the latest results from the Prospective Population Study of Women, which has been following the health status of 1,500 women since the 1960s. Blood analysis has shown that middle-aged women with high levels of the amino acid homocysteine are twice as likely to develop Alzheimer’s disease years later. As well, the risk of any type of dementia for these women was 70% higher than women with the lowest levels of homocysteine. It’s unclear whether the relationship between Alzheimer’s and homecysteine is direct or indirect. If, in fact, future studies support this claim homocysteine levels may be an easy way to determine those at risk even before the onset of symptoms. [via EmaxHealth]
Share your comments here.
Posted by Steven / November 8, 2009 7:48 pm / Permalink / Comments (4) / Trackbacks (0)
November 5, 2009
The Drug and Therapeutics Bulletin, a monthly review of pharmacotherapeutics in medicine published by the British Medical Journal, is recommending that physicians take a second look before prescribing daily low-dose aspirin to patients. A recent review of European data questions whether there is any benefit at all for those without a history of cardiovascular disease to be taking a daily aspirin, especially since long-term low-dose aspirin therapy almost doubles the likelihood of gastrointestinal bleeding (a potentially serious side effect). The journal authors support continued use of aspirin in those with known cardiovascular disease, such as diabetes, high blood pressure and heart attacks. But, in light of current evidence, is not recommending daily low-dose aspirin for prevention of cardiovascular disease. [via Drug and Therapeutics Bulletin]
Share your comments here.
Posted by Steven / November 5, 2009 6:30 pm / Permalink / Comments (8) / Trackbacks (0)
November 3, 2009
Integrative medicine is a hot field right now with more and more patients exploring complimentary and alternative treatments. Why shouldn’t some of these remedies work? After all, plenty of medicines are derived from the nature around us. One such example is lovastatin (also known by the brand name Mevacor), a medication used to lower cholesterol which is derived from red yeast rice, a supplement used in Traditional Chinese Medicine since 800 A.D. that’s produced by cultivating a red-colored mold on rice. A study published in the current issue of Annals of Internal Medicine demonstrates the efficacy of red yeast rice in improving the lipid profiles of people with high cholesterol. When compared with another popular cholesterol-lowering medication, simvastatin (Zocor), red yeast rice was able to lower LDL levels just as effectively. But, similar to prescription lipid-lowering drugs, red yeast rice can have similar side effects on the liver and muscles. So why isn’t your physician recommending red yeast rice? The reasons are plenty, but one main cause is the currently under-regulated U.S. supplements industry where it may be difficult to accurately know how much of a medicinally active ingredient you are receiving, and consistently so. Regardless, red yeast rice may be a viable alternative for cholesterol reduction in certain people who may not be able to tolerate synthetically manufactured medications due to their side effects. [via Annals of Internal Medicine]
Share your comments here.
Posted by Steven / November 3, 2009 10:29 pm / Permalink / Comments (3) / Trackbacks (0)
November 1, 2009
New technologies developed after studying shark skin will soon be appearing at a hospital near you. Scientists at Sharklet Technologies, a Florida-based biotech company, have been studying shark skin for the interesting fact that bacteria just doesn’t seen to stick to it. Under the microscope, it appears that shark skin is composed of diamond-shaped bumps that give it this unique property. Hospital tests using plastic tubing (as used in intravenous lines and catheters) printed with this shark skin pattern showed that microorganisms which can cause potentially serious harm, such as E. coli and Staphylococcus Aureus, were unable to establish colonies large enough to infect humans. The technology is currently pending FDA approval for medical use, but in the interim look out for Sharklet to appear on high-touch surfaces like restroom door handles later this year. [via Popular Science]
Share your comments here.
Posted by Steven / November 1, 2009 9:41 pm / Permalink / Comments (2) / Trackbacks (0)
October 28, 2009
Campaign for Safe Cosmetics, a coalition of US-based non-profit health and environmental groups just released a report regarding contamination of Halloween face paints by heavy metals. Although the CDC recommends against using cosmetics which contain lead on children, there’s no way of telling whether the paints contain toxic metals since they are not required to be listed on product labels (there is no legal requirement to list them because they’re considered contaminants, not ingredients). The group looked at 10 children’s face paint brands and found:
- 10 out of 10 children’s face paints contained lead at levels between 0.05 and 0.65 parts per million (ppm).
- 6 out of 10 children’s face paints contained nickel, cobalt and/or chromium at levels between 1.6 to 120 ppm (this is much higher than the industry safety standard of 1 ppm said the report). These metals can be allergens in children.
- Snazaroo Face Paint contained some of the highest levels of lead, nickel and cobalt found in the study. This product carries the words “non-toxic” and “hypoallergenic” on its label.
Continue reading at Medical News Today.
Share your comments here.
Posted by Steven / October 28, 2009 8:34 pm / Permalink / Comments (4) / Trackbacks (0)
October 26, 2009

Did you know that carbonation has a distinct taste? According to new research from the National Institute of Dental and Craniofacial Research scientists have elucidated the fine intricacies of fizziness. When consuming a carbonated beverage the sensation of tiny bubbles bursting on your tongue is, in fact, misleading. If one were to drink a soda in a pressure chamber (thus preventing the bubbles from bursting) the sensation would actually be the same. What gives? The “taste” of carbonation involves the interaction of an enzyme, carbonic anhydrase 4, with the sour-sensing cells in your taste buds. This interaction sends signals to the brain where carbonation is perceived as the familiar fizz, followed by a sensation of tartness. [via NIH News]
Share your comments here.
Posted by Steven / October 26, 2009 9:07 pm / Permalink / Comments (3) / Trackbacks (0)